Guanglin Zhou - Concepedia

Author

Guanglin Zhou

Tianjin Medical University Cancer Institute and Hospital

Also Known As

Guanglin Zhou, Ningmei Yu, Zhifeng Li

Publications

299

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and Hospital King's College London

About

Guanglin Zhou is an author at Tianjin Medical University Cancer Institute and Hospital specializing in cancer research, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	127
2	Cell Biology	3	3	127
3	Cancer Cell Biology	2	2	86
4	Cancer Genetics	2	2	86
5	Health Sciences	1	1	38

Guanglin Zhou

Publications

287

Citations

H-Index

Page 1

	Year	Citations
Correlations Between <i>LNCRNA-SOX2OT</i> Polymorphism and Susceptibility to Breast Cancer in a Chinese Population Xiuwu Tang, Yan Gao, Linxiang Yu, Biomarkers in Medicine	2017	61
Tanshinone I and Tanshinone IIA/B attenuate LPS-induced mastitis via regulating the NF-κB Lili Yang, Guanglin Zhou, Jinghua Liu, Biomedicine & Pharmacotherapy	2021	58
USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway Yawen Tan, Guanglin Zhou, Xianming Wang, International Journal of Oncology Breast Cancer GrowthBreast OncologyAkt/skp2 PathwayCancer BiologyMammary Gland Development	2018	48
Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer Shaorong Zhao, Teng Pan, Jinhai Deng, British Journal of Cancer Tumor BiologyMedicineCancer GenomicsCellular SenescenceBreast Cancer	2022	41
Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2 Teng Pan, Dongdong Zhou, Zhendong Shi, Cancer Letters Breast OncologyMedicineUbiquitin–proteasomal DegradationCancer Cell BiologyProtein Degradation	2019	38
Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer Jinhai Deng, Teng Pan, Chunxin Lv, Theranostics	2023	31
<scp>HSP</scp>90 inhibitor <scp>AUY</scp>922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells Jingchao Bai, Guanglin Zhou, Yufan Qiu, Cancer Science	2017	10

Page 1